Image Analysis Group (IAG) has been a valued partner to biotech and pharmaceutical companies for nearly 20 years. We are optimizing clinical trial design and delivery through our award-winning platform DYNAMIKA and AI-powered endpoints, accelerating the assessment of efficacy and safety for novel drug candidates to ultimately deliver the promise of health and longevity to people worldwide.
As a leading Imaging Clinical Research Organization (iCRO), we combine cutting-edge technology with a robust operational infrastructure, ensuring seamless execution of clinical trials across the globe. Our extensive reach and expertise enable us to support pharmaceutical and biotech companies in achieving their clinical development goals efficiently.
Operational Excellence
Global Presence: Our operational teams and project managers are strategically located in the UK, EU, USA, India, and partnership in China and Australia providing comprehensive support for phase 1-3 trials and real-world studies.
Experienced Project Management: Our seasoned project managers have a proven track record of successfully managing complex clinical trials, ensuring timely delivery and adherence to regulatory standards.
Global Site Netwrok: We maintain a well-connected network of sites and radiology readers, facilitating rapid site set-up and efficient data collection.
Innovative Solutions
DYNAMIKA: Our proprietary Digital Data Management infrastructure maximizes efficiencies in handling imaging data, offering streamlined site set-up, monitoring, and advanced image review capabilities.
AI-Powered Endpoints: We leverage advanced AI algorithms to analyze vast amounts of data, enhancing safety assessments and improving efficacy evaluations.
Therapeutic Expertise
Our team has extensive experience in a wide range of therapeutic areas, including musculoskeletal disorders, oncology, immunology, obesity, rheumatology, neuroscience, CNS disorders, and rare diseases. This expertise, combined with our Medical and Scientific advisory teams, supports optimal trial design and protocol development.
Since 2007, we’ve successfully delivered over 700 clinical trials, continuously pushing the boundaries of what’s possible in clinical research. Our commitment to operational excellence, innovative technology, and patient-centric approach positions us at the forefront of the industry, driving the development of better medicines, faster.
At IMAGE ANALYSIS GROUP, we’re not just transforming clinical trials – we’re accelerating the path to a healthier, longer-living world through effective partnerships and cutting-edge solutions.
Read more about our partnerships